Clarinase 5 mg/120 mg tablete s produljenim oslobađanjem
| Name | Clarinase 5 mg/120 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-352905247 |
| Active Substance | loratadin pseudoefedrinsulfat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 5 mg loratadina i 120 mg pseudoefedrinsulfata |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | SAG Manufacturing S.L.U., San Agustin del Guadalix, Madrid, Španjolska |
| Marketing Authorisation Holder | Bayer d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.08.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/272 |
| Registration Number | 381-12-01/70-18-07 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R06AX13; R01BA52 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o riziku od sindroma posteriorne reverzibilne encefalopatije i sindroma reverzibilne cerebralne vazokonstrikcije uz primjenu lijekova koji sadrže pseudoefedrin | 09.02.2024 | Alkaloid d.o.o., Bayer d.o.o., Pliva Hrvatska d.o.o., Reckitt Benckiser d.o.o., Krka - farma d.o.o., Bosnalijek d.o.o., Jadran Galenski laboratorij d.d. |
